Arcturus Therapeutics Holdings Inc. (ARCT)

NASDAQ: ARCT · IEX Real-Time Price · USD

23.79

+0.37 (1.58%)

At close: Jul 19, 2024, 4:00 PM

24.50

+0.71 (2.98%)

Pre-market: Jul 22, 2024, 8:08 AM EDT

ARCT Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2011
Net Income	-107.3	-29.73	9.35	-203.67	-72.15	-25.99	Upgrade
Depreciation & Amortization	3.28	2.96	1.53	1.19	0.88	0.68	Upgrade
Share-Based Compensation	36.56	34.65	30.61	28.92	6.76	1.98	Upgrade
Other Operating Activities	79.67	-25.98	-9.49	38.52	21.64	16.88	Upgrade
Operating Cash Flow	12.22	-18.1	31.99	-135.04	-42.86	-6.45	Upgrade
Operating Cash Flow Growth	-72.95%	-	-	-	-	-	Upgrade
Capital Expenditures	-2.45	-2.9	-7.73	-3.41	-1.74	-0.82	Upgrade
Investing Cash Flow	-2.45	-2.9	-7.73	-3.41	-1.74	-0.82	Upgrade
Share Issuance / Repurchase	5.47	3.28	2.14	1.42	436.15	36.96	Upgrade
Debt Issued / Paid	0	-27.36	-5	46.6	0	4.95	Upgrade
Financing Cash Flow	5.47	-24.09	-2.86	48.02	436.15	41.91	Upgrade
Net Cash Flow	15.23	-45.09	21.41	-90.43	391.54	34.64	Upgrade
Free Cash Flow	9.77	-21	24.27	-138.45	-44.6	-7.26	Upgrade
Free Cash Flow Growth	-74.87%	-	-	-	-	-	Upgrade
Free Cash Flow Margin	7.84%	-12.59%	11.78%	-1120.23%	-467.59%	-34.94%	Upgrade
Free Cash Flow Per Share	0.36	-0.79	0.92	-5.26	-2.20	-0.60	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).